Carmat

CARMAT has opened its second production facility (BDA2) in Bois-d'Arcy, France, approved by DEKRA for production of the Aeson total artificial heart. Combined with the existing BDA1 facility, it will enable a production capacity of 500 hearts per year by early 2024.

Vygon has signed an exclusive agreement with Carmat to develop a new vascular graft for the Aeson artificial heart, the world's first highly hemocompatible, pulsatile and self-regulating bioprosthetic artificial heart.